Intellectual Property Magazine
COVAX project announces new vaccine agreements
WHO and Gavi-backed vaccine access scheme announces it will obtain 40m doses of the Pfizer-BioNTech vaccine and 100m doses of AstraZeneca/Oxford vaccine
Ben Wodecki
The World Health Organization’s (WHO) fair and equitable Covid-19 vaccine access project, COVAX, has purchased up to 40m doses
of the Pfizer-BioNTech vaccine candidate.